Liver cancer: discovering the next generation of therapy targets
For decades, the fight against cancer has focused on killing the tumour cell. We treated cancer like an isolated entity that needed to be destroyed – but what if we’ve been looking at the wrong target? In this episode, we delve into the critical insight that cancer is not just a ...عرض المزيد
Biologics- engineering tomorrow’s medicines
Therapies and drugs have evolved enormously in the last 30 years. For example, in cancer, where previously our options were limited to surgery, chemotherapy and radiotherapy, we’re now hearing terms like cancer immunotherapy, targeted therapies and even cancer vaccines. Many of t ...عرض المزيد
حلقات موصى بها
How Food, Fasting & Lifestyle Can Transform Your Metabolic Health & Reduce Your Risk of Disease with Dr Ben Bikman #582
Most of us will never have our insulin levels tested, yet this single hormone is the body’s master regulator of energy. When it stops working properly, almost every system in the body is affected, from how we store fat, to how we age. Today’s guest is Dr Ben Bikman, a scientist a ...عرض المزيد
#267 Think clearer and stay sharp with these brain health strategies from Neurophysiologist Dr Louisa Nicola
According to Alzheimer's research UK, over 50% of everyone listening to this podcast will be affected by dementia by either contracting the disease ourselves, caring for somebody with the disease or both.Dementia is due to impact 130 million people globally by 2050, and today it ...عرض المزيد
#274 Why we age and what we can do to stop it with Prof Richard Faragher
Six conditions cause the majority of deaths in the world, these include dementia and cardiovascular disease. Traditionally, we’ve looked at these conditions through the lens of what goes wrong individually, such as blocked arteries around the heart or tangles of proteins that imp ...عرض المزيد
#333 ‒ Longevity roundtable — the science of aging, geroprotective molecules, lifestyle interventions, challenges in research, and more | Steven Austad, Matt Kaeberlein, Richard Miller